WSJ: Allergan said today that the FDA has approved its drug Latisse for “hypotrichosis of the eyelashes.†The company, which also sells Botox, helpfully explains that this is “another name for having inadequate or not enough eyelashes.†It’s a prescription drug that’s applied daily.
Comment count on this article reflects comments made on Breitbart.com and Facebook. Visit Breitbart's Facebook Page.